SCHEMBL10280359

SCHEMBL10280359

CCC1(NC(=O)c2cc(C#N)cc(C)c2NC(=O)c2cc(OCC(F)(F)F)nn2-c2ncccc2Cl)CS(=O)(=O)C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 5/20 0.33
SLC2A3 P11169 5/20 0.33
SLC2A4 P14672 5/20 0.33
SLC2A2 P11168 2/20 0.33
DGAT2 Q96PD7 1/20 0.32
GCK P35557 2/20 0.32
KCNH2 Q12809 2/20 0.32
MGAT2 Q10469 3/20 0.31
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
CACNA1H O95180 4/20 0.31
CACNA1G O43497 3/20 0.31
CACNA1I Q9P0X4 2/20 0.31
P2RY12 Q9H244 1/20 0.31
CYP3A4 P08684 1/20 0.31
CACNA1C Q13936 1/20 0.31
CNR2 P34972 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10279970 0.92 DGAT2 (0.37) SLC2A1SLC2A3SLC2A4SLC2A2DGAT2
SCHEMBL10280536 0.92 DGAT2 (0.34) DGAT2CACNA1HCACNA1GCACNA1ICNR2
SCHEMBL14470569 0.91 DGAT2 (0.33) DGAT2CACNA1HCACNA1GCACNA1ICNR2
SCHEMBL10280361 0.91 KLKB1 (0.35) SLC2A1SLC2A3SLC2A4SLC2A2P2RY12
SCHEMBL10280395 0.87 DHODH (0.37) SLC2A1SLC2A3SLC2A4SLC2A2DGAT2
SCHEMBL10280357 0.86 MGAT2 (0.36) SLC2A1SLC2A3SLC2A4SLC2A2DGAT2
SCHEMBL10280399 0.86 SLC2A1 (0.34) SLC2A1SLC2A3SLC2A4SLC2A2DGAT2
SCHEMBL5620493 0.85 SLC2A1 (0.36) SLC2A1SLC2A3SLC2A4SLC2A2GCK
SCHEMBL15147427 0.85 SLC2A1 (0.41) SLC2A1SLC2A3SLC2A4SLC2A2CACNA1H
SCHEMBL31060075 0.85 SLC2A1 (0.41) SLC2A1SLC2A3SLC2A4SLC2A2CACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278464-B2 Insecticides SYNGENTA CROP PROTECTION LLC (US) 2012-10-02 US disclosed
US-20120077991-A1 NOVEL INSECTICIDES SYNGENTA CROP PROTECTION, LLC 2012-03-29 US disclosed
US-8084474-B2 Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2011-12-27 US disclosed
US-8084474-B2 Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2011-12-27 US disclosed
US-20100168066-A1 NOVEL INSECTICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-07-01 US disclosed
US-20100168066-A1 NOVEL INSECTICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077991-A1 NOVEL INSECTICIDES DDT, CYP4F11, ACHE SLC2A1 3522/4885SLC2A3 4067/4885SLC2A4 3985/4885
US-20100168066-A1 NOVEL INSECTICIDES DDT, ACHE, CYP4F11 SLC2A1 4053/4885SLC2A3 4338/4885SLC2A4 4327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.